Tight control of rheumatoid arthritis (RA) disease activity requires frequent disease monitoring and adjustment of therapy, as often as every 3 to 6 months. Unfortunately, the American College of Rheumatology (ACR) recommendations are sometimes not followed in clinical practice, particularly the use of disease activity measures, the application of treat-to-target recommendations, and the implementation of ACR treatment algorithms, leading to suboptimal patient care. This series of patient visit scenarios will allow you to make management decisions, benchmark your scores against those of your peers, and hear from experts in the field.
Upon completion of this activity, participants should be better able to:
William J. Koopman Endowed Professor, Rheumatology and Immunology
Director, UAB Arthritis Clinical Intervention Program
Co-Director, UAB Center for Education and Research on Therapeutics
(CERTS) of Musculoskeletal Disorders
Co-Director, UAB PharmacoEpidEmiology and phaRmcoeconomics (PEER) Unit
University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology
Clinical Associate Professor, Medicine
Drexel University School of Medicine
Assistant Professor, Division of General Internal Medicine
Hospital for Special Surgery
Division of Rheumatology
Weill Cornell Medicine
New York, NY
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources